Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure

American Heart Journal

Volumn 138, Issue 2 I, 1999, Pages 285-290

  Weinfeld, M S ^a   Chertow, G M ^a   Stevenson, L W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIURESIS; FEMALE; HEART FAILURE; HEART OUTPUT; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY DISEASE; KIDNEY PERFUSION; LENGTH OF STAY; MALE; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME;

EID: 0032799699     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(99)70113-4     Document Type: Article

References (34)

1. Dzau VJ. Renal and circulatory mechanisms in congestive heart failure. Kidney Int 1987;31:1402-15.
2. Leier CV, Boudoulas H. Renal disorders and the heart. In: Braunwald E, editor. Heart disease. Philadelphia: WB Saunders; 1997. p. 1914-38.
3. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1975;16:31-41.
4. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976;37:7-12.
5. Leithe ME, Margorien RD, Hermiller JB, Unverferth DV, Leier CV. Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation 1984;69:57-64.
6. Hollenberg NK. Control of renal perfusion and function in congestive heart failure. Am J Cardiol 1988;62:72E-75E.
7. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978;233:233-43.
8. Viquerat CE, Daly P, Swedberg K, et al. Endogenous catecholamine levels in chronic heart failure: relation to the severity of hemodynamic abnormalities. Am J Med 1985;78:455-60.
9. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 1992;85:504-9.
10. Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation 1990;82:1724-9.
11. Cody RJ, Atlas SA, Laragh JH, et al. Atrial natriuretic factor in normal subjects and heart failure patients: plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest 1986;78:1362-74.
12. Kohzuki M, Hodsman GP, Johnston CI. Attenuated response to atrial natriuretic peptide in rats with myocardial infarction. Am J Physiol 1989;256:H533-8.
13. Hare J, Colucci WS. Role of nitric oxide in the regulation of myocardial dysfunction. Prog Cardiovasc Dis 1995;38:155-66.
14. Ichikawa I, Pfeffer JM, Pfeffer MA, Hostetter TH, Brenner BM. Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res 1984;55:669-75.
15. Cody RJ, Ljungman S, Covit AB, et al. Regulation of glomerular filtration rate in chronic congestive heart failure patients, Kidney Int 1988;34:361-7.
16. Packer M, Lee WH, Kessler PD. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system. Circulation 1986;74:766-74.
17. Rose BD. Acute renal failure - prerenal disease versus acute tubular necrosis. In: Rose BD, editor. Pathophysiology of renal disease. New York: McGraw-Hill; 1987. p. 65-117.
18. Tauchi H, Tsuboi K, Okutomi J. Age changes in the human kidney of the different races. Geront 1971;17:87-97.
19. Cody RJ, Torre S, Clark M, Pondolfino K. Age-related hemodynamic, renal, and hormonal differences among patients with congestive heart failure. Arch Intern Med 1989;149:1023-8.
20. Ausma J, Wijffels M, Thone F, Wouters L, Allesie M, Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997;96:3157-63.
21. Stevenson LW, Tillisch JH. Maintenance of cardiac output with normal filling pressures in dilated heart failure. Circulation 1986;74:1303-8.
22. Stevenson LW, Belil D, Grover-McKay M, et al. Effects of afterload reduction on left ventricular volume and mitral regurgitation in severe congestive heart failure. Am J Cardiol 1987;60:654-8.
23. Leier CV. Regional blood flow responses to vasodilators and inotropes in congestive heart failure. Am J Cardiol 1988;62:86E-93E.
24. Thames MD, Miller BD, Abboud FM. Baroreflex regulation of renal nerve activity during volume expansion. Am J Physiol 1982; 243:H810-4.
25. Myers BD, Peterson C, Molina C, et al. Role of cardiac atria in the human renal response to changing plasma volume. Am J Physiol 1988;254:F562-73.
26. Raine AEG, Erne P, Burgisser E, et al. Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure. N Engl J Med 1986;315:533-7.
27. Wei C-M, Kao PC, Lin J-T, Heublein DM, Schaff HV, Burnett JC. Circulating b-atrial natriuretic factor in congestive heart failure in humans. Circulation 1993;88:1016-20.
28. Johnson W, Omland T, Collins CM, Stevenson LW. Neurohormonal activation rapidly decreases after intravenous vasodilator and diruetic therapy for class IV heart failure [abstract]. Circulation 1998;98:I-780.
29. Shannon RP, Libby E, Elahi D, et al. Impact of acute reduction in chronically elevated left atrial pressure on sodium and water excretion. Ann Thor Surg 1988;46:430-7.
30. Gupta BN, Abboud AL, Floras JS, Aylward PE, Abboud FM. Vasopressin facilitates inhibition of renal nerve activity mediated through vagal afferents. Am J Physiol 1987;253:H1-7.
31. Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S et al. Endothelin in human congestive heart failure. Circulation 1994;89:1580-6.
32. Packer M, Lee WH, Medina N, Yushak M. Influence of renal function on the hemodynamic and clinical responses to long-term captopril therapy in severe chronic heart failure. Ann Intern Med 1986; 104:147-54.
33. Steimle AE, Stevenson LW, Chelimsky-Fallick C, et al. Sustained hemodynamic efficacy of therapy tailored to reduce filling pressure in survivors with advanced heart failure. Circulation 1997;96:1165-72.
34. Yoshimura M, Yasue H, Morita E, et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991;84:1581-8.